找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Research Methods for Chinese Medicine; Siu-wai Leung,Hao Hu Book 2016 Springer Science+Business Media Singapore 2016 Chines

[復(fù)制鏈接]
樓主: 適婚女孩
21#
發(fā)表于 2025-3-25 06:18:24 | 只看該作者
22#
發(fā)表于 2025-3-25 11:13:34 | 只看該作者
23#
發(fā)表于 2025-3-25 15:30:56 | 只看該作者
Eduardo González,José María Martínez-Valdisease (PD) are the most common and challenging neurological diseases which lack effective treatment. Chinese medicine (CM) is an ancient yet still alive medical system widely used by Asian people for preventing and treating diseases. The symptoms of stroke, AD, and PD have been described in CM boo
24#
發(fā)表于 2025-3-25 19:11:23 | 只看該作者
Maria Laura Parisi,Riccardo Basosifection, as well as development and metastasis of cancer. Targeting of chemokine receptors has become a therapeutic strategy and the selective chemokine receptor antagonists have important therapeutic implications. One of such examples is the anti-HIV effect of inhibitors of CC-chemokine receptor 5
25#
發(fā)表于 2025-3-25 23:52:51 | 只看該作者
26#
發(fā)表于 2025-3-26 03:28:27 | 只看該作者
27#
發(fā)表于 2025-3-26 05:26:33 | 只看該作者
28#
發(fā)表于 2025-3-26 10:07:46 | 只看該作者
29#
發(fā)表于 2025-3-26 12:40:07 | 只看該作者
Energy Saving and Carbon Reductionn case of unavailable or impractical primary outcomes. The composite outcomes can also capture the multidimensional nature of disease, seek a comprehensive response to intervention, and thus could be especially important for complex intervention including CM. The development and validation of a comp
30#
發(fā)表于 2025-3-26 16:47:35 | 只看該作者
Actions to Develop and their Impact,cebo-controlled trial is an explanatory trial since it tests the known mechanisms associated with the treatment. But in hands-on therapies like acupuncture what can constitute a valid placebo control treatment? Are there predictable mechanisms by which acupuncture works suggesting which valid placeb
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-30 07:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
泾川县| 潞西市| 永春县| 焦作市| 惠州市| 信宜市| 衡阳市| 清徐县| 封丘县| 松桃| 随州市| 临漳县| 林芝县| 察隅县| 紫云| 巴马| 庆元县| 遂平县| 梨树县| 福州市| 定安县| 合水县| 吉安市| 长寿区| 中超| 兴和县| 永吉县| 武夷山市| 疏附县| 平远县| 新野县| 南陵县| 新乡县| 荣成市| 太仓市| 南通市| 青浦区| 崇礼县| 富川| 博罗县| 济南市|